|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-5-26
|
|
pubmed:abstractText |
Cholangiocarcinoma (CC) is devastating neoplasm and very few specific biomarkers could be used in clinical diagnosis. A study was taken to find novel serum biomarkers for CC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1097-4644
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
745-55
|
|
pubmed:meshHeading |
pubmed-meshheading:18275060-Adult,
pubmed-meshheading:18275060-Aged,
pubmed-meshheading:18275060-Aged, 80 and over,
pubmed-meshheading:18275060-Bile Duct Neoplasms,
pubmed-meshheading:18275060-Bile Ducts, Intrahepatic,
pubmed-meshheading:18275060-CA-19-9 Antigen,
pubmed-meshheading:18275060-Case-Control Studies,
pubmed-meshheading:18275060-Cholangiocarcinoma,
pubmed-meshheading:18275060-Female,
pubmed-meshheading:18275060-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:18275060-Humans,
pubmed-meshheading:18275060-Male,
pubmed-meshheading:18275060-Middle Aged,
pubmed-meshheading:18275060-Prealbumin,
pubmed-meshheading:18275060-Tumor Markers, Biological
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Serum levels of variants of transthyretin down-regulation in cholangiocarcinoma.
|
|
pubmed:affiliation |
Key Laboratory for Cell Proliferation and Regulation Biology, Ministry of Education, Beijing Normal University, The People's Republic of China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
